Farmak’s specialists have improved the formula of Injesta ampoule progesterone. The improved preparation is produced under “Injesta” name. The medicine has wide indications range in obstetrics and gynaecology.
Injesta is produced in form of 1% or 2,5% solution for injections. The medicine contains a new form of ethyl oleate with viscosity 13 times less than oil solution that allows quicker medicine absorption and its quicker and entire dissolution in tissues. It also ensures accurate and constant progesterone concentration in blood, and it is well-resolved (this prevents graomas and abscesses in place of injection), and ensures painless injections.
Natalia Levchenko, Farmak’s Specialist of Ophthalmologic and Dermatological Drugs Department: “Injesta has wide indications range in obstetrics and gynaecology”. In particular, in case of non-carrying of pregnancy, threat of miscarriage, amenorrhea, dysfunctional metrorrhagia, sterility.
When buying Corvalol, consumers mean a drug under the brand of Farmak, which has been produced at the plant since 1959. This conclusion was made by International Marketing Group during its study of the level of consumer awareness of the drug marked “CORVALOL”. Most of the respondents surveyed noted that the drug called “Corvalol” is […]
As part of the celebration of the 60th anniversary of the first release of Corvalol manufactured by Farmak, leader of the Ukrainian pharmaceutical market, the Ukrainian Book of Records has recognized Corvalol by Farmak as the most known sedative in Ukraine. Corvalol by Farmak is a globally known medicinal product that has already become a […]
On Sunday, February 24, the final matches within UFAM League 3rd season (Kyiv Open Futsal Championship among health care institutions) took place. The tournament which started at the end of 2018 was ended with the great sport and health event. 12 teams participated in the competition this year, including the players from the Cardiology Institute, Kyiv [&hell...